rs1057518223
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001110556.2(FLNA):c.4599-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001110556.2 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- periventricular nodular heterotopiaInheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- frontometaphyseal dysplasia 1Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
- genetic developmental and epileptic encephalopathyInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- heterotopia, periventricular, X-linked dominantInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Illumina
- intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linkedInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Melnick-Needles syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- otopalatodigital syndrome type 2Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- terminal osseous dysplasia-pigmentary defects syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- cardiac valvular dysplasia, X-linkedInheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- frontometaphyseal dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital short bowel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- otopalatodigital syndrome type 1Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked Ehlers-Danlos syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- familial thoracic aortic aneurysm and aortic dissectionInheritance: XL Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FLNA | ENST00000369850.10 | c.4599-1G>A | splice_acceptor_variant, intron_variant | Intron 27 of 47 | 1 | NM_001110556.2 | ENSP00000358866.3 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The c.4599-1 G>A likely pathogenic variant in the FLNA gene has not been reported as a pathogenic or benign variant to our knowledge. This single nucleotide substitution disrupts the intron 27 canonical splice acceptor and is predicted to cause abnormal gene splicing. Many other splice site variants in the FLNA gene have been reported in HGMD in association with PH (Stenson et al., 2014). Furthermore, the c.4599-1 G>A variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project and was not present in Exome Aggregation Consortium, indicating it is not a common benign variant in these populations. In summary, the c.4599-1 G>A variant in the FLNA gene is expected to be pathogenic -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at